Telix stock: UBS update highlights diagnostics cash engine
BYD's Six-Seat Flagship Arrives as Daiwa and BofA Pare Back Their Price Targets
Lenzing's Heiligenkreuz Deadline Is the Test That Counts, Not the Number of Bids
UBS Crosses 5% Threshold in Renk as Defence Group Lines Up New Finance Chief and US Autonomy Trial
Siemens Draws Divergent Analyst Calls as Healthineers Spin-Off Reshapes the Investment Case
Deep Yellow stock: Citi ceases to be substantial holder
Geely stock gets Renault distribution deal for Argentina
Mineral Resources stock names Michael Ellis as CFO from May 2027
Seatrium stock wins MODEC FPSO integration contract in Guyana
IREN stock: Bernstein keeps Buy rating and sets USD 55 target
BYD Electronic stock: Morgan Stanley sets HKD 23 target
Xero stock: Citi keeps Buy rating, sets AUD 95.40 target
Flex stock: Axiom secures 4.565 billion US dollars in commitments
CapitaLand Investment stock: AUD 105 million Melbourne hotel plan
Zip Co stock: AGM backs proposed five-for-one share consolidation
Rheinmetall's Order Book Keeps Growing — the Question Is When It Turns Into Revenue
Siemens Energy Pushes Turbine Peak to 2035 as Record Orders Meet a 5.1% AI-Driven Slide
NEXTDC stock gets FY27 revenue and EBITDA guidance upgrade
Yangzijiang stock revives RMB3.38 billion clean-energy yard project
Baidu stock gets AI cloud boost as Q3 growth returns
Santos stock: Duratec wins four-year maintenance contract
Vulcan Energy Hits 52-Week Low as Morgan Stanley Holds and SQM Flags Softer Prices
Novo Nordisk Wins FDA Nod for Weekly Sogroya in Turner Syndrome as Buyback Passes DKK 12 Billion
Micron Sinks With AI Chip Peers as Investors Weigh Hype Against Hard Numbers
Xiaomi Cancels 58.5 Million Treasury Shares as JPMorgan Slashes Q3 Profit Outlook
Infineon's Record Quarter Is in the Books; the €20 Billion Forecast Is the Real Test
Vanguard's All-World ETF Sits 8.8% Below Its October Peak as Investors Buy the Dip
TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack
Anthropic Listing Fails to Halt Chip Rout as VanEck ETF Slides on AI Payback Worries
BioNTech Lifts 2026 Revenue Guidance Midpoint as Roche Takes Over Partner Program R&D Costs
Evonik's Independence Test: Union Pressure on RAG-Stiftung Meets a Sharper Earnings Picture
Marvell's Patent Truce and Board Expansion Greet a Halved Price Target
Allgeier SE confirms rumors regarding sale process for the Evora Group
Deutsche Bank's Cost Discipline Meets Its Toughest Test Yet